Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00107640 · ClinicalTrials.gov registry record · Phase 2
Project SHARE (Senior Health and Alcohol Risk Education)
A Phase 2 study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,186
- Enrollment target
NCT00107640: Completed Phase 2 study, sponsored by University of California, Los Angeles.
NCT00107640 is a Phase 2 study that has completed, run by University of California, Los Angeles. The registered enrollment target is 1,186 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (792% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00107640, a Phase 2 study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,186 participants
- Enrollment target
Study Summary
Older adults become more sensitive to alcohol, and alcohol also interacts adversely with their common medical conditions and medications. The aim of Project SHARE (Senior Health and Alcohol Risk Education) is to see whether patient and provider education can decrease risky alcohol use and reduce health care costs in persons 60 years of age and older.
Primary Outcome
At-risk drinking is alcohol use that (either alone or in conjunction with selected comorbidities, symptoms and/or medications) poses health risks. It is measured using the CARET instrument developed by Moore and colleagues.
Interventions
- BEHAVIORAL Patient-provider education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,186 participants |
| Start Date | 2005-05 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
What the finished NCT00107640 record still lists
NCT00107640 is an interventional study that assigns participants to a tested intervention. Its 1,186 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (792% higher).
The record links to 0 conditions, and to 1 intervention - of which Patient-provider education is the first listed.
NCT00107640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00107640 about?
NCT00107640 is a clinical study titled "Project SHARE (Senior Health and Alcohol Risk Education)". Older adults become more sensitive to alcohol, and alcohol also interacts adversely with their common medical conditions and medications. The aim of Project SHARE (Senior Health and Alcohol Risk Education) is to see whether patient and provider education can decrease risky alcohol use and reduce hea...
What is the current status of trial NCT00107640?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,186 participants. The study started on 2005-05. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00107640?
The interventions under investigation include: Patient-provider education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00107640?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00107640's enrollment target sits among peer trials
1,186 18th of 2000 higher than 1,983 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia